Veradigm Inc. (MDRX)
OTCMKTS
· Delayed Price · Currency is USD
4.850
+0.050 (1.04%)
Dec 4, 2025, 4:00 PM EST
Veradigm Market Cap
Veradigm has a market cap or net worth of $815.80 million as of December 5, 2025. Its market cap has decreased by -56.69% in one year.
Market Cap
815.80M
Enterprise Value
588.65M
Revenue
588.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.85
Market Cap Chart
Since October 13, 2008, Veradigm's market cap has increased from 311.82M to 815.80M, an increase of 161.63%. That is a compound annual growth rate of 5.77%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 558.58M |
| Glass House Brands | 531.36M |
| CytoDyn | 403.93M |
| American Oncology Network | 367.13M |
| Northwest Biotherapeutics | 364.92M |
| Silence Therapeutics | 336.78M |
| Nika Pharmaceuticals | 259.91M |
| HST Global | 131.71M |